Health Trials

Waldenström's Macroglobulinemia

2

Review clinical trials related to Waldenström's Macroglobulinemia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Zanubrutinib in Patients With Waldenström's Macroglobulinemia, Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma and Follicular Lymphoma

The objective of this NIS is to evaluate medical resource utilization, where data is rare in all cohorts, patient's QoL and effectiveness of zanubrutinib treatment in adult patients with WM, CLL, MZL and FL in a real-world setting.

Participants needed: 705
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: iOMEDICO AGUpdated: Sep 23, 2025Locations: 2
Eligibility criteria

Waldenström's macroglobulinemia (all treatment lines) OR [+8]

Contraindications according to SmPC for patients with WM, CLL, MZL or FL [+1]

Read more
Status: Recruiting

R-VRD Followed by Lenalidomide Maintenance in Patients With Waldenstrom's Macroglobulinemia

A multicenter prospective phase II study of rituximab combined, lenalidomide, dexamethasone followed by lenalidomide maintenance in patients with newly diagnosed Waldenström's macroglobulinemia (Ballondor trial)

Participants needed: 54
Trial details
Phase: Phase 2Age: 19+Biological sex: AllType: InterventionalSponsor: Kosin University Gospel HospitalUpdated: Oct 6, 2023Locations: 1
Eligibility criteria

Clinicopathological diagnosis of Waldenstrom's Macroglobulinemia [+8]

Central nervous system involvement central nervous system (CNS) involvement by W... [+16]

Read more